Combating coxsackievirus B infections.

Alhazmi, Abdulaziz; Nekoua, Magloire Pandoua; Mercier, Ambroise; Vergez, Ines; Sane, Famara; Alidjinou, Enagnon Kazali; Hober, Didier

Type de document :

Article dans une revue scientifique: Article de synthèse/Review paper

DOI :

10.1002/rmv.2406

PMID :

36371612

URL permanente :

http://hdl.handle.net/20.500.12210/102822

Titre :

Combating coxsackievirus B infections.

Auteur(s) :

Alhazmi, Abdulaziz [Auteur]
Laboratoire de Virologie - ULR 3610 [Laboratoire de Virologie]
Nekoua, Magloire Pandoua [Auteur]
Laboratoire de virologie - ULR 3610
Mercier, Ambroise [Auteur]
Laboratoire de Virologie - ULR 3610 [Laboratoire de Virologie]
Vergez, Ines [Auteur]
Laboratoire de Virologie - ULR 3610 [Laboratoire de Virologie]
Sane, Famara [Auteur]

Laboratoire de virologie - ULR 3610
Alidjinou, Enagnon Kazali [Auteur]

Laboratoire de virologie - ULR 3610
Hober, Didier [Auteur]

Laboratoire de virologie - ULR 3610

Titre de la revue :

Reviews in Medical Virology

Nom court de la revue :

Rev Med Virol

Numéro :

Pagination :

e2406

Date de publication :

2022-11-15

ISSN :

1099-1654

Discipline(s) HAL :

Sciences du Vivant [q-bio]/Microbiologie et Parasitologie/Virologie

Résumé en anglais : [en]

Coxsackieviruses B (CVB) are small, non-enveloped, single-stranded RNA viruses belonging to the Enterovirus genus of the Picornaviridae family. They are common worldwide and cause a wide variety of human diseases ranging ...
Lire la suite >Coxsackieviruses B (CVB) are small, non-enveloped, single-stranded RNA viruses belonging to the Enterovirus genus of the Picornaviridae family. They are common worldwide and cause a wide variety of human diseases ranging from those having relatively mild symptoms to severe acute and chronic pathologies such as cardiomyopathy and type 1 diabetes. The development of safe and effective strategies to combat these viruses remains a challenge. The present review outlines current approaches to control CVB infections and associated diseases. Various drugs targeting viral or host proteins involved in viral replication as well as vaccines have been developed and shown potential to prevent or combat CVB infections in vitro and in vivo in animal models. Repurposed drugs and alternative strategies targeting miRNAs or based on plant extracts and probiotics and their derivatives have also shown antiviral effects against CVB. In addition, clinical trials with vaccines and drugs are underway and offer hope for the prevention or treatment of CVB-induced diseases.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

Université de Lille
CHU Lille

Collections :

Laboratoire de virologie - ULR 3610

Date de dépôt :

2024-01-17T22:04:54Z
2024-02-09T10:38:44Z

Numéro de version	Lien	Date de modification
2	20.500.12210/102822*	2024-02-09T10:36:47Z
1	20.500.12210/102822.1	2024-01-17T22:04:54Z

Combating coxsackievirus B infections.

BibTeX

CSV

Excel

RIS

Historique des modifications

Combating coxsackievirus B infections. BibTeX CSV Excel RIS

Historique des modifications

Combating coxsackievirus B infections.

BibTeX

CSV

Excel

RIS